NCT07529262 2026-04-14
AspiRe HCC
Curtin University
Phase 3 Not yet recruiting
Clinical Trials
16 trialsNCT07441681 2026-04-03
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
NRG Oncology
Phase 3 Not yet recruiting
NCT07311057 2026-01-06
Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy
Mashhad University of Medical Sciences
Phase 3 Enrolling by invitation
NCT07135882 2025-08-22
PRIME-Lung
Trans Tasman Radiation Oncology Group
Phase 3 Not yet recruiting
NCT03556839 2025-01-08
BEATcc
Grupo Español de Investigación en Cáncer de Ovario
Phase 3 Active not recruiting
NCT04747054 2024-10-26
PembroMetaRT
UNICANCER
Phase 3 Recruiting
NCT02539537 2024-01-09
NEOPAN
UNICANCER
Phase 3 Completed
NCT00606866 2023-11-29
MRI
University of Chicago
Phase 3 Completed
NCT01855451 2022-11-18
HPVOropharynx
Trans Tasman Radiation Oncology Group
Phase 3 Unknown
NCT02526953 2021-02-09
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
Blokhin's Russian Cancer Research Center
Phase 3 Unknown
NCT04225299 2020-11-13
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Steba Biotech S.A.
Phase 3 Withdrawn
NCT01310894 2019-07-11
PCM301
Steba Biotech S.A.
Phase 3 Completed
NCT01875393 2016-04-19
PCM304
Steba Biotech S.A.
Phase 3 Completed
NCT00983684 2014-12-05
TARGIT
University College, London
Phase 3 Completed
NCT00935675 2009-09-02
Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown
NCT00126269 2006-09-08
Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown